|
ASH2L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.10070000009155E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79369999964152E-07 |
| Normal-vs-Stage2 |
9.064800E-03 |
| Normal-vs-Stage3 |
3.144200E-03 |
| Normal-vs-Stage4 |
2.618800E-03 |
| Stage1-vs-Stage2 |
9.923800E-01 |
| Stage1-vs-Stage3 |
6.503000E-01 |
| Stage1-vs-Stage4 |
7.860500E-02 |
| Stage2-vs-Stage3 |
6.969000E-01 |
| Stage2-vs-Stage4 |
1.136430E-01 |
| Stage3-vs-Stage4 |
3.156300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.32380000000565E-05 |
| Normal-vs-AfricanAmerican |
1.47390000004854E-06 |
| Normal-vs-Asian |
4.712200E-02 |
| Caucasian-vs-AfricanAmerican |
4.228800E-01 |
| Caucasian-vs-Asian |
2.445200E-01 |
| AfricanAmerican-vs-Asian |
1.144750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.88750000021487E-07 |
| Normal-vs-Female |
1.059680E-02 |
| Male-vs-Female |
9.129600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.433100E-04 |
| Normal-vs-Extreme_Weight |
4.6271000031517E-08 |
| Normal-vs-Obese |
2.983100E-04 |
| Normal-vs-Extreme_Obese |
1.707520E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.915000E-01 |
| Normal_Weight-vs-Obese |
4.700600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.616000E-01 |
| Extreme_Weight-vs-Obese |
1.410440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.239400E-01 |
| Obese-vs-Extreme_Obese |
1.998000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.894630E-01 |
| Normal-vs-Age(41-60Yrs) |
3.77320000000125E-05 |
| Normal-vs-Age(61-80Yrs) |
8.07940000000507E-05 |
| Normal-vs-Age(81-100Yrs) |
2.302100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.791800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.547200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.228600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.598600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.524000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.291000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.5731999999975E-05 |
| Normal-VS-Type2 PRCC |
2.765300E-04 |
| Normal-VS-KIRP CIMP |
2.746200E-02 |
| Normal-VS-Unclassified PRCC |
3.743800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.042000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.516800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.284000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.579410E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.785600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.074000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.77600000448453E-08 |
| Normal-vs-N1 |
8.764000E-01 |
| Normal-vs-N2 |
2.006800E-01 |
| N0-vs-N1 |
1.817760E-01 |
| N0-vs-N2 |
6.993200E-01 |
| N1-vs-N2 |
5.135800E-01 |
|
|
